OncoMatch

OncoMatch/Clinical Trials/NCT07803315

Hyperspectral Imaging in Robot-Assisted Partial Nephrectomy

Is NCT07803315 recruiting? Yes, currently enrolling (Sep 2026).

RecruitingUniversity of LeipzigNCT07803315Data as of Sep 2026Location: Germany

The goal of this prospective observational study is to learn about the use of a novel imaging technique called hyperspectral imaging in adult participants who are having surgery for removing a tumor from their kidney. Hyperspectral imaging works by shining light on a structure (in this case, the kidney tissue with the tumor) and capturing how it reflects hundreds of very narrow color bands, including ones the human eye can't see. These patterns depend on the composition of the tissue and for example how well blood is flowing through the tissue. By studying these patterns, the investigators want to understand if this technique can be helpful for the surgery where only the part of the kidney with the tumor is removed. The main questions it aims to answer are: * Can hyperspectral imaging show the areas of blood flow in the kidney during surgery? * Is there a connection between the detected patterns of light and the type of kidney tumor? The imaging will happen during the already planned surgery and the participant does not need to undergo any additional tests.

Check if I qualify

Extracted eligibility criteria

Prior therapy

Cannot have received: surgery on affected kidney

patients with a previous surgery on the affected kidney

Cannot have received: nephrotoxic chemotherapy

previous malignancy with ongoing or planned nephrotoxic chemotherapy

Structured fields extracted by AI. May contain errors — verify against the official protocol.

Frequently asked questions

Is NCT07803315 currently recruiting?

Yes, this trial is currently recruiting patients.

Are there prior therapy exclusions?

Yes. Prior surgery on affected kidney, nephrotoxic chemotherapy disqualifies patients from enrollment.

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify